1. Home
  2. TRAW
  3. TRAW News

Latest TRAWS PHARMA INC (TRAW) News on July 12, 2025

Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions
TRAW

GlobeNewswire

12 days ago

Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions

Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
TRAW

GlobeNewswire

a month ago

Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib

Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness
TRAW

GlobeNewswire

a month ago

Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness

Traws Pharma Reports First Quarter 2025 Results and Business Highlights
TRAW

GlobeNewswire

2 months ago

Traws Pharma Reports First Quarter 2025 Results and Business Highlights

Traws Pharma Reports Full Year 2024 Results and Business Highlights
TRAW

GlobeNewswire

3 months ago

Traws Pharma Reports Full Year 2024 Results and Business Highlights

Traws Pharma Announces Management Updates
TRAW

GlobeNewswire

3 months ago

Traws Pharma Announces Management Updates

Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
TRAW

GlobeNewswire

4 months ago

Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET

Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR
TRAW

GlobeNewswire

4 months ago

Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR

Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates
TRAW

GlobeNewswire

4 months ago

Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates

Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR
TRAW

GlobeNewswire

4 months ago

Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR

Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil
TRAW

GlobeNewswire

4 months ago

Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil

Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule
TRAW

GlobeNewswire

4 months ago

Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule

Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu
TRAW

PR Newswire

6 months ago

Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu

Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program
TRAW

PR Newswire

6 months ago

Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program

Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval
TRAW

PR Newswire

6 months ago

Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
TRAW

PR Newswire

7 months ago

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu

Traws Pharma Provides Business Update and Reports Q3 2024 Financial Results
TRAW

GlobeNewswire

8 months ago

Traws Pharma Provides Business Update and Reports Q3 2024 Financial Results

Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil
TRAW

GlobeNewswire

9 months ago

Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil

Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro Inhibitor
TRAW

GlobeNewswire

9 months ago

Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro Inhibitor

TRAW

GuruFocus.com

10 months ago

Orbimed Advisors LLC Reduces Stake in Traws Pharma Inc

Upcoming Stock Splits This Week (September 23 to September 27) – Stay Invested
TRAW

TipRanks

10 months ago

Upcoming Stock Splits This Week (September 23 to September 27) – Stay Invested

Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors
TRAW

GlobeNewswire

10 months ago

Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors

Traws Pharma, Inc. Announces Special Shareholders Meeting Results
TRAW

GlobeNewswire

10 months ago

Traws Pharma, Inc. Announces Special Shareholders Meeting Results

Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights
TRAW

GlobeNewswire

a year ago

Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights

Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET
TRAW

GlobeNewswire

a year ago

Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET

Edge Total Intelligence Inc. Updates Status of MCTO
TRAW

Newsfile

a year ago

Edge Total Intelligence Inc. Updates Status of MCTO

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024
TRAW

GlobeNewswire

a year ago

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers
TRAW

GlobeNewswire

a year ago

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting
TRAW

GlobeNewswire

a year ago

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
TRAW

CNW Group

a year ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
TRAW

GlobeNewswire

a year ago

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
TRAW

CNW Group

a year ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
TRAW

PR Newswire

a year ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
TRAW

GlobeNewswire

a year ago

Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate

Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
TRAW

GlobeNewswire

a year ago

Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update

Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy
TRAW

GlobeNewswire

a year ago

Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy

Traws Pharma Full Year 2023 Earnings: Beats Expectations
TRAW

Simply Wall St.

a year ago

Traws Pharma Full Year 2023 Earnings: Beats Expectations

Share on Social Networks: